Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillator Therapy in Patients With Tetralogy of Fallot

J Am Coll Cardiol. 2022 Oct 25;80(17):1701-1703. doi: 10.1016/j.jacc.2022.08.761.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Death, Sudden, Cardiac
  • Defibrillators, Implantable*
  • Humans
  • Tetralogy of Fallot* / therapy
  • Treatment Outcome

Associated data

  • ClinicalTrials.gov/NCT03837574